The Damon Runyon Cancer Research Foundation has awarded a $450,000 grant to an investigator studying T cells at City of Hope in Duarte. Elizabeth Budde, MD, PhD, Assistant Professor in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope, Duarte, received The Jake Wetchler Foundation for Innovative Pediatric Cancer Research-Damon Runyon Cancer Research Foundation Clinical Investigator award, which will support a 3-year study of immunotherapy treatment for AML.
“Support such as this generous award is critical to our clinical research efforts,” said Steven T. Rosen, MD, Provost and Chief Scientific Officer at City of Hope. “The project that Dr. Budde has developed will expand the field of T-cell immunotherapy in a very significant way and extend the benefit of treatment to patients with few options.”
Dr. Budde leads the research under the mentorship of Stephen J. Forman, MD, the Francis and Kathleen McNamara Distinguished Chair in Hematology and Hematopoietic Cell Transplatation at City of Hope. ■
